Search results
Results From The WOW.Com Content Network
galderma .com. Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it has been held by a consortium of private institutional investors since 2019. Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal, then it ...
Cetaphil / ˈ s iː t ə f ɪ l / or / ˈ s ɛ t ə f ɪ l / is a line of skin care products from the Swiss company Galderma, including cleansers, bar soap, cream, lotion, and moisturizers.It was developed in 1947 in Texas [1] and is commonly sold at over 70 grocery stores and pharmacies including the United States, Canada, India and Nepal.
Financials as of March 31, 2024. [update] [ 1] McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Proactiv is an American brand of skin-care products developed by two American dermatologists, Katie Rodan and Kathy A. Fields, and launched in 1995 by Guthy-Renker, a California-based direct marketing company, that was endorsed by famous celebrities [2] The range includes moisturizers, body washes and treatment products, but the brand is known for its three-step anti-acne Solutions 3-step ...
Storonsky said the company’s “exceptional financial performance” had been driven by a 46% jump in customers, bringing the company’s total to 38 million customers across the now 38 ...
Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma [2] since October 2019. He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. [3] He previously worked for Bayer, Bausch & Lomb and Novartis.